ADVERTISEMENT
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Related topics
PRESS RELEASE: Paid content from Globe Newswire
Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Opiant Pharmaceuticals to Participate in September Investor Conferences

August 25, 2021 GMT

SANTA MONICA, Calif., Aug. 25, 2021 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (Nasdaq: OPNT) today announced that members of the company’s senior management team will participate in the following virtual investor conferences:

  • H.C. Wainwright 23rd Annual Global Investment Conference
    September 13-15, 2021
    On-demand presentation will be available at 7:00am ET on September 13; hosting 1-on-1 meetings

  • Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
    September 20-23, 2021
    Presentation on September 20 at 4:35 pm ET; hosting 1-on-1 meetings

  • Cantor 2021 Virtual Global Healthcare Conference 
    September 27-30, 2021
    Fireside chat on September 29 at 4:00 pm ET; hosting 1-on-1 meetings

A webcast of each presentation and fireside chat will be accessible on the  Opiant website.

ADVERTISEMENT

About Opiant Pharmaceuticals, Inc. 
Opiant Pharmaceuticals, Inc., the company that developed NARCAN® Nasal Spray, is building a leading franchise of new medicines to combat addictions and drug overdose. For more information visit:  www.opiant.com.

For Media and Investor Inquiries:
Ben Atkins, Opiant
(310) 598-5410
batkins@opiant.com